Miller Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Miller Wealth Advisors's BMY Position: Q2 2026 in Review
Miller Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 143% in Q2 2026, buying an estimated $23.1K and bringing the position to 684 shares worth $25.3K. The position accounts for 0.01% of the portfolio, ranked #49.
Miller Wealth Advisors first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $196K in Q1 2023. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Miller Wealth Advisors held 684 shares of Bristol-Myers Squibb worth $25.3K as of Q2 2026.
- Miller Wealth Advisors bought 403 Bristol-Myers Squibb shares in Q2 2026, an estimated $23.1K.
- Bristol-Myers Squibb made up 0.01% of Miller Wealth Advisors's portfolio in Q2 2026, its #49 holding.
- Miller Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Miller Wealth Advisors's Bristol-Myers Squibb position peaked at $196K in Q1 2023.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.